HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- (2- (4- (5H- dibenzo(a,d)cyclohepten- 5- yliden)piperidino)ethyl)- 1- formyl- 4- piperidinecarboxamide (AT 1015)

structure in first source
Also Known As:
AT 1015; (N-(2-(4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-piperidino)ethyl)-1-formyl-4-piperidinecarboxamide monohydrochloride monohydrate); AT-1015; N-(2-(4-(5H-dibenzo(a,d)cyclohepten-5-yliden)piperidino)ethyl)-1-formyl-4-piperidinecarboxamide monohydrochloride monohydrate
Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Yamamoto, H: 2 articles (12/2001 - 04/2000)
2. Koganei, H: 2 articles (12/2001 - 04/2000)
3. Kihara, H: 2 articles (12/2001 - 04/2000)
4. Yoshimoto, R: 2 articles (12/2001 - 04/2000)
5. Hirose, K: 2 articles (12/2001 - 04/2000)
6. Komiyama, Takashi: 1 article (03/2004)
7. Hirose, Ken: 1 article (03/2004)
8. Kihara, Hideaki: 1 article (03/2004)
9. Yoshimoto, Ryota: 1 article (03/2004)
10. Shigematsu, Hiroshi: 1 article (03/2004)

Related Diseases

1. Intermittent Claudication
2. Peripheral Vascular Diseases (Peripheral Vascular Disease)
3. Thrombosis (Thrombus)
4. Ischemia

Related Drugs and Biologics

1. 5-HT2A Serotonin Receptor (5 HT2A Receptor)